Utz O. Krug

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Journal: Blood
Published: October 14, 2025

Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Journal: Blood
Published: October 14, 2025

Characterizing Overall Survival of Patients with Acute Myeloid Leukemia: A Competing Risk Analysis of SEER Data Covering 46 Years.

Characterizing Overall Survival of Patients with Acute Myeloid Leukemia: A Competing Risk Analysis of SEER Data Covering 46 Years.

Journal: Cancers
Published: September 18, 2025

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Journal: Leukemia
Published: August 15, 2025

Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences.

Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences.

Journal: HemaSphere
Published: March 11, 2025

Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment.

Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment.

Journal: Leukemia
Published: February 20, 2025

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Journal: Leukemia
Published: January 28, 2025

Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia.

Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia.

Journal: Leukemia
Published: January 24, 2025

Differential diagnosis of Guillain-Barré syndrome: steroid-responsive radiculopathy in Evans syndrome.

Differential diagnosis of Guillain-Barré syndrome: steroid-responsive radiculopathy in Evans syndrome.

Journal: Neurological research and practice
Published: May 14, 2024

Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia.

Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia.

Journal: Blood advances
Published: April 03, 2024

Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia.

Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia.

Journal: Innovation (Cambridge (Mass.))
Published: March 25, 2024

Prognostic impact of CEBPA mutational subgroups in adult AML.

Prognostic impact of CEBPA mutational subgroups in adult AML.

Journal: Leukemia
Published: October 30, 2023
Showing 1-12 of 74

Last Updated: 09/26/2026